Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-008191
Filing Date
2020-07-10
Accepted
2020-07-10 17:28:01
Documents
1
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3844
  Complete submission text file 0001179110-20-008191.txt   5369
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Issuer) CIK: 0001130598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GENTA INC TWO CONNELL DR BERKELEY HEIGHTS NJ 07922
Business Address
GROOPMAN JEROME (Reporting) CIK: 0001218853 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36020 | Film No.: 201023873